# SAM #6912710440008

VA award for emergency Pluvicto and Lutathera radiopharmaceuticals

**Buyer:** VA 262 Network Contract Office 22
**Posted:** October 29, 2026
**Identifier:** 6912710440008
**NAICS:** 325412, 424210

The Department of Veterans Affairs awarded a one-month emergency bridge order for cancer-treatment radiopharmaceuticals at VA Greater Los Angeles Healthcare System.
- Government buyer
  - Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Network Contracting Office 22.
- Award and supplier
  - Award amount: $769,496.80.
  - **OEM and supplier: Novartis Pharmaceuticals Corporation**, identified as the only authorized source listed in the VA NAC catalog.
- Products requested
  - **Pluvicto** — radiopharmaceutical radioligand therapy for cancer; quantity and part number not stated.
  - **Lutathera** — radiopharmaceutical radioligand therapy for cancer; quantity and part number not stated.
- Notable requirements
  - The one-month bridge order is intended to maintain continuity of cancer care while the longer-term FY 2027 order is finalized.
  - The justification cites urgent patient-care needs and the proprietary, specialized nature of the medications.
  - Per-injection prices are not provided.

[View original listing](https://sam.gov/opp/c7c5938680f6440f92c6c54059150665/view)